ADVANT Altana’s expertise in the Pharma / Life Sciences sector has evolved considerably with the expansion of the team since 2017. ADVANT Altana assists and advises health care industry leaders, particularly pharmaceutical companies, with strategic solutions to optimize their performance and meet their objectives, be it in complex product liability and regulatory matters, intellectual property, or transactional and contentious matters.

ADVANT Altana’s Pharmaceutical and Life Science’s practice advises and represents clients in complex domestic and international product liability matters. It handles individual and serial cases before Civil, Administrative and Criminal courts and is one of the rare firms in France to have developed a strong expertise in Healthcare class actions (ADVANT Altana is notably handling two class actions, including the first pharmaceutical product liability class action in France). Additionally, clients rely on the firm’s capacity to manage complex international matters and oversee the implementation of a chosen strategy across several jurisdictions.

ADVANT Altana has also developed a strong expertise in Intellectual Property relating to the Healthcare industry, accompanying clients with all aspects of intellectual property registration, protection and enforcement and representing clients in complex trademark and patent litigation, with a growing focus on the biotech industry, e-health and the use of the Big Data in the medical field.  The team also acts as prominent counsel for its corporate and investor clients on mergers, acquisitions, spinoffs and joint ventures, providing a seamless capacity to navigate through the regulatory and compliance issues specific to the industry, particularly in emerging markets where the industry is undergoing double-digit growth.

The service value and singular approach of our team are recognized by Legal 500 and by our peers in Best Lawyers in the Life Sciences section.